HCPCS J9145

Injection, daratumumab, 10 mg (CMS descriptor)

Drugs Drug code Work RVU per service none (2021 fee schedule; adds 0 work RVUs)

74
61st percentile among 6,253 codes billed · 2021
$24M
93rd percentile among 6,253 codes billed · 2021
529K
93rd percentile among 6,253 codes billed · 2021
5,281
98th percentile among 6,253 codes billed · 2021
18,310
98th percentile among 6,253 codes billed · 2021
–
Not compared: 2021 changed office visit values · 2021

Trend

Medicare payment on the code

$0$25M$50M2020: $58M paid20202021: $24M paid20212022: $9.8M paid20222023: $8.9M paid2023$8.9M$0$25M$50M2020: $58M paid20202021: $24M paid20212022: $9.8M paid20222023: $8.9M paid2023$8.9M$0$25M$50M2020: $58M paid20202021: $24M paid20212022: $9.8M paid20222023: $8.9M paid2023$8.9M$0$25M$50M2020: $58M paid20202021: $24M paid20212022: $9.8M paid20222023: $8.9M paid2023$8.9M

Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2024.

Billers

01002002020: 206 providers20202021: 74 providers20212022: 23 providers20222023: 14 providers20232024: 5 providers2024501002002020: 206 providers20202021: 74 providers20212022: 23 providers20222023: 14 providers20232024: 5 providers2024501002002020: 206 providers20202021: 74 providers20212022: 23 providers20222023: 14 providers20232024: 5 providers2024501002002020: 206 providers20202021: 74 providers20212022: 23 providers20222023: 14 providers20232024: 5 providers20245

Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2024.

observed calculated calculated calculated calculated calculated reported
20245fewer than 11 billers: figures not shown0.00
202314$8,877,712-10% (2023 changed hospital and observation visit codes)189,37411,76529,4280.00
202223$9,813,090-59%217,9555,65024,5120.00
202174$23,698,730– (Not compared: 2021 changed office visit values)529,2895,28118,3100.00
2020206$57,759,412first year in data1,342,3614,58016,5890.00

Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2024.

By state

observed calculated calculated calculated calculated calculated
Texas13$4,623,138103,2465,58019,614
Colorado13$2,142,85347,8003,4705,216

Not listed: 17 states with fewer than 11 billers (small cells).

Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Providers placed by practice address. Data year 2021.

Top metro areas

No metro area has a reportable line for J9145 in 2021.

Specialties billing J9145 nationally

Hematology-Oncology accounts for 65% of payment for J9145 nationally in 2021, across 1 specialties on claims.

observed calculated calculated calculated calculated calculated
Hematology-Oncology4764%$15,434,44065%345,5737,353

Not listed: 4 specialties with fewer than 11 billers (small cells).

Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Provider-level lines (fewer than 11 beneficiaries suppressed by CMS); specialty is the provider type on claims. Data year 2021.

Top billers of J9145 nationally

Named top billers are a Pro figure, and Pro is not available to buy, so this list is not shown to any account. The counts and totals by state, metro area and specialty on this page are free.

Original Medicare Part B fee-for-service only; CMS suppresses provider lines with fewer than 11 beneficiaries. How these figures are computed · Limitations